As a highly specialized orphan drug platform company, we facilitate access to therapies for rare disease patients in Latin America. We build a bridge between USA and EU based orphan drug biotech companies and Latin American markets.

We also provide consulting services to biotech companies to explore the opportunity to make their products available and accessible in the region.